219 results
Keyword Cinacalcet Aristo Remove keyword
-
List item
National expert: Amalia Papadaki, National Organization For Medicines (updated)
- Declaration of interests - 39.2 KB | PDF
- Curriculum Vitae - 28.32 KB | PDF
Subject: Aristotle University of Thessaloniki • … -
List item
Human medicine European public assessment report (EPAR): BindRen
colestilan, Hyperphosphatemia
Date of authorisation: 21/01/2013,, Revision: 2, Withdrawn, Last updated: 01/04/2015
-
List item
Information Management (updated)
Last updated: 03/11/2023degree in Mathematics, Aristotle University of Thessaloniki …
-
List item
National expert: Maria Stavrou, Pharmaceutical Services Ministry Of Health (updated)
- Declaration of interests - 39.21 KB | PDF
- Curriculum Vitae - 29.99 KB | PDF
United Kingdom 2. Subject: ARISTOTELION UNIVERSITY OF THESSALONIKI • … -
List item
National expert: Marios Genakritis, Ministry Of Agriculture Rural Development And Environment (updated)
- Declaration of interests - 39.31 KB | PDF
- Curriculum Vitae - 36.99 KB | PDF
-
List item
National expert: Evangelia Giannaki, National Organization For Medicines (updated)
- Declaration of interests - 41.71 KB | PDF
- Curriculum Vitae - 90.78 KB | PDF
• 09/1981 - 04/1988 MD Medicine, Aristotelian University of Thessaloniki … -
List item
National expert: George Aislaitner, Federal Institute for Drugs and Medical Devices (updated)
- Declaration of interests - 39.21 KB | PDF
- Curriculum Vitae - 39.5 KB | PDF
United Kingdom 7. Subject: Aristotle University of Thessaloniki • … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 19-22 June 2017
CHMP, Last updated: 23/06/2017Name of medicine Mimpara INN cinacalcet Marketing-authorisation holder … -
List item
Withdrawn application: Xgeva
denosumab, date of withdrawal: 13/01/2017, Post-authorisation, Last updated: 05/05/2017 -
List item
National expert: Maria Kladi, National Organization For Medicines (updated)
- Declaration of interests - 39.2 KB | PDF
- Curriculum Vitae - 37.27 KB | PDF
Department of Chemistry, Aristotle University of Thessaloniki • … -
List item
National expert: Sotirios Nedios, European Medicines Agency (updated)
- Declaration of interests - 42.17 KB | PDF
- Curriculum Vitae - 211.43 KB | PDF
with animal experiments), Aristotle University of Thessaloniki … -
List item
Referral: Synchron
Article 31 referrals
Status: European Commission final decision, opinion/position date: 19/05/2022, EC decision date: 28/11/2022, Last updated: 16/12/2022 -
List item
National expert: Maria Gomes Da Silva, European Medicines Agency (updated)
- Declaration of interests - 43.41 KB | PDF
- Curriculum Vitae - 227.05 KB | PDF
-
List item
Referral: Topiramate (updated)
topiramate, Article 31 referrals
Status: CMDh final position, opinion/position date: 10/11/2023, Last updated: 23/11/2023 -
List item
Referral: Nomegestrol and chlormadinone
nomegestrol, chlormadinone, associated names: Zoely, Article 31 referrals
Status: European Commission final decision, opinion/position date: 01/09/2022, EC decision date: 28/11/2022, Last updated: 14/12/2022 -
List item
National expert: Ioanna Chinou, National Organization For Medicines (updated)
- Declaration of interests - 39.21 KB | PDF
- Curriculum Vitae - 65.07 KB | PDF
principles from the roots of Aristolochia longa L." J.Hinou, C.Demetzos … -
List item
Referral: Ulipristal acetate 5mg medicinal products
ulipristal acetate, associated names: Esmya, Ulipristal Acetate Gedeon Richter, Article 31 referrals
Status: European Commission final decision, opinion/position date: 12/11/2020, EC decision date: 11/01/2021, Last updated: 03/02/2021 -
List item
Referral: Semler
Article 31 referrals
Status: European Commission final decision, opinion/position date: 21/07/2016, EC decision date: 22/09/2016, Last updated: 17/11/2016 -
List item
Referral: Ranitidine-containing medicinal products
ranitidine, Article 31 referrals
Status: European Commission final decision, opinion/position date: 17/09/2020, EC decision date: 24/11/2020, Last updated: 17/02/2021 -
List item
Referral: Valproate and related substances
sodium valproate, valproate magnesium, valproate semisodium, valproic acid, valpromide, associated names: Absenor, Convival Chrono, Convulex, Delepsine, Depakin, Depakine, Depakote, Depamag, Depamide, Deprakine, Diplexil, Dipromal, Epilim, Episenta, Epival, Ergenyl, Espa-Valept, Hexaquin, Kentlim, Leptilan, Micropakine L.P., Orfiril, Petilin, Valepil, Valhel PR, Valpal, Valpro and Valprolek, Article 31 referrals
Status: European Commission final decision, opinion/position date: 21/03/2018, EC decision date: 31/05/2018, Last updated: 07/06/2018 -
List item
Referral: Flupirtine-containing medicinal products
flupirtine, Article 31 referrals
Status: CMDh final position, opinion/position date: 21/03/2018, Last updated: 04/05/2018 -
List item
Referral: Metformin and metformin-containing medicines
metformin, associated names: Xigduo, Vipdomet, Velmetia, Synjardy, Ristfor, Komboglyze, Jentadueto, Janumet, Icandra (previously Vildagliptin / metformin hydrochloride Novartis), Glubrava, Eucreas, Efficib, Ebymect, Competact, Article 31 referrals
Status: European Commission final decision, opinion/position date: 13/10/2016, EC decision date: 12/12/2016, Last updated: 21/12/2016 -
List item
Referral: Valproate and related substances
sodium valproate, valproic acid, valproate semisodium, valpromide, associated names: Absenor, Convival Chrono, Convulex, Convulsofin Tabletten, Delepsine, Depakine, Deprakine, Diplexil, Dipromal, Epilim, Episenta, Epival, Ergenyl, Espa-Valept, Hexaquin, Leptilan, Micropakine L.P., Orfiril, Orlept, Petilin, Valberg, Valepil and Valhel, Article 31 referrals
Status: CMDh final position, opinion/position date: 19/11/2014, Last updated: 29/01/2015 -
List item
Referral: Tetrazepam-containing medicines
tetrazepam, associated names: Myolastan and generics, Article 107i procedures
Status: European Commission final decision, opinion/position date: 24/04/2013, EC decision date: 29/05/2013, Last updated: 18/07/2013 -
List item
Referral: Ambroxol and bromhexine-containing medicines
ambroxol, bromhexine, Article 31 referrals
Status: European Commission final decision, opinion/position date: 18/11/2015, EC decision date: 14/01/2016, Last updated: 05/02/2016